ArticleThe Journal of infectious diseases2023

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.

Dimitrios Paraskevis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.